Bayer is discontinuing its Calantic Digital Solutions AI platform and ceasing Blackford Analysis services, signaling a major retreat from the radiology AI platform sector.
Key Details
- 1Bayer will exit the radiology AI software platform business, discontinuing Calantic and Blackford Analysis offerings.
- 2Calantic was launched in 2022 and built on Blackford's platform, which Bayer fully acquired in 2023.
- 3Blackford's platform currently hosts over 150 third-party AI apps from more than 60 developers across multiple clinical domains.
- 4A dedicated Bayer team will handle the transition, honoring existing contracts; future sale plans for Blackford are not confirmed.
- 5Industry experts suggest the move may trigger a consolidation wave in the radiology AI platform market and signal underlying adoption and integration challenges.
Why It Matters
Bayer’s withdrawal removes a key player and nearly 10% of spending from the global radiology AI platform ecosystem, raising concerns about the long-term viability of the platform model and potentially slowing broader AI adoption in radiology due to market uncertainty and loss of confidence.
Source
AuntMinnie
Related News
•AuntMinnie
AI in Breast Imaging Achieves High NPV but Raises Recall Rates
AI systems in breast imaging yield near-perfect negative predictive value but increase recall rates compared to radiologists, particularly for intermediate-risk classifications.
•AuntMinnie
How Agentic AI Is Transforming Imaging Interoperability
Agentic AI can automate complex, non-standard tasks in imaging interoperability, reducing manual work and improving efficiency.
•Cardiovascular Business
Former US Surgeon General Jerome Adams Joins Eko as Medical Advisor
Former US Surgeon General Jerome Adams has joined Eko Health as a distinguished medical advisor to support AI-powered cardiac and pulmonary detection technologies.